Scotts Miracle-gro CO Form 4 insider transactions

James Hagedorn, CEO and Chairman of Scotts Miracle-Gro, acquired 1,339.542 shares of phantom stock on December 26, 2024.

Executive Vice President, CFO, and Chief Administrative Officer of Scotts Miracle-Gro, Garth Matthew E., reports a transaction of common shares.

Nathan E. Baxter, EVP and COO of Scotts Miracle-Gro, reports a transaction involving common shares held through a partnership.

Scotts Miracle-Gro CEO James Hagedorn reported the acquisition of common shares through two transactions and details of his beneficial ownership, including shares held indirectly through a 401(k) plan and a partnership.

A Scotts Miracle-Gro executive, Christopher C. Hagedorn, exercised stock options to acquire company shares.

The Hagedorn Partnership sold a substantial number of Scotts Miracle-Gro Co. common shares in multiple transactions on December 9, 2024.

Robert Hagedorn, a director at Scotts Miracle-Gro, sold a total of 108,550 common shares in two transactions on December 9, 2024.

James Hagedorn, CEO and Chairman of Scotts Miracle-Gro, acquired 1,740.647 shares of phantom stock on December 6, 2024.

Director Edith Aviles acquired 58 dividend equivalent rights related to Scotts Miracle-Gro common stock on December 6, 2024.

David C. Evans, an executive at Scotts Miracle-Gro, has been granted dividend equivalent rights linked to existing share-based awards.

Adam Hanft, an executive at Scotts Miracle-Gro, has been granted dividend equivalent rights linked to his existing stock-based compensation.

Roberto Candelino has filed a document regarding dividend equivalent rights related to his holdings in Scotts Miracle-Gro Co.

Katherine Hagedorn Littlefield, a director at Scotts Miracle-Gro, acquired 15 dividend equivalent rights on December 6, 2024.

Mark D. Kingdon, an executive at Scotts Miracle-Gro, has been granted dividend equivalent rights linked to his existing stock awards.

Nathan Eric Baxter, EVP and COO of Scotts Miracle-Gro, sold 11,359 common shares in multiple transactions on December 9, 2024.

Peter E. Shumlin, an executive at Scotts Miracle-Gro, has been granted dividend equivalent rights tied to previously awarded stock units.

Stephen L. Johnson, an executive at Scotts Miracle-Gro, has been granted dividend equivalent rights tied to his existing stock awards.

John R. Vines, an executive at Scotts Miracle-Gro, has been granted dividend equivalent rights linked to his existing stock-based compensation.

Thomas N. Kelly Jr., an executive at Scotts Miracle-Gro Co., has been granted dividend equivalent rights linked to previously awarded stock units.

Brian E. Sandoval, a director at Scotts Miracle-Gro, acquired 101 dividend equivalent rights on December 6, 2024.

Scotts Miracle-Gro CEO and Chairman James Hagedorn sold 18,368 common shares at an average price of $75.6769 on December 4, 2024.

Matthew E. Garth, EVP, CFO & Chief Admin Officer of Scotts Miracle-Gro, sold 3,123 common shares to cover tax obligations.

Hagedorn Partnership, a significant shareholder in Scotts Miracle-Gro Co, has sold a portion of its holdings in multiple transactions.

Scotts Miracle-Gro CEO and Chairman, James Hagedorn, acquired 1,143.244 shares of phantom stock on November 26, 2024.

Executive Vice President and COO of Scotts Miracle-Gro, Nathan Baxter, reports the acquisition and disposal of company shares on November 14, 2024.

Scotts Miracle-Gro CEO James Hagedorn acquired 32,425 common shares and disposed of 14,057 shares on November 14, 2024.

Executive Vice President, CFO & Chief Admin Officer of Scotts Miracle-Gro, Matthew Garth, reports the acquisition and disposal of company shares on November 14, 2024.

Christopher Hagedorn, Division President at Scotts Miracle-Gro, reports the acquisition and disposal of company shares on November 14, 2024.

Executive Vice President, General Counsel, and Corporate Secretary of Scotts Miracle-Gro, Dimiter Todorov, reports acquisition and disposal of company shares.

Scotts Miracle-Gro CEO James Hagedorn was granted 126,051 stock options on November 8, 2024, exercisable between 2027 and 2034.